• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

首例因依帕列净引起的药疹：病例报告及文献复习

First case of drug eruption due to ipragliflozin: Case report and review of the literature.

作者信息

Saito-Sasaki Natsuko, Sawada Yu, Nishio Daisuke, Nakamura Motonobu

机构信息

Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan.

出版信息

Australas J Dermatol. 2017 Aug;58(3):236-238. doi: 10.1111/ajd.12502. Epub 2016 May 31.

DOI:10.1111/ajd.12502
PMID:27242192
Abstract

Ipragliflozin is a new drug for the treatment of diabetes mellitus. Its action of sodium-glucose cotransporter 2 (SGLT2) inhibition induces glucosuria and decreases blood glucose levels. We report the first case of ipragliflozin-related eczematous drug eruption and a review of the past literature on drug eruptions caused by SGLT2 inhibitors.

摘要

依帕列净是一种用于治疗糖尿病的新药。其对钠-葡萄糖协同转运蛋白2（SGLT2）的抑制作用可导致糖尿并降低血糖水平。我们报告了首例与依帕列净相关的湿疹样药疹病例，并对过去有关SGLT2抑制剂引起的药疹的文献进行了综述。

相似文献

1
First case of drug eruption due to ipragliflozin: Case report and review of the literature.首例因依帕列净引起的药疹：病例报告及文献复习
Australas J Dermatol. 2017 Aug;58(3):236-238. doi: 10.1111/ajd.12502. Epub 2016 May 31.
2
Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor.使用SGLT2抑制剂依帕列净治疗后出现的非典型酮症酸中毒和持续性高血糖尿症
Intern Med. 2017;56(13):1673-1678. doi: 10.2169/internalmedicine.56.7945. Epub 2017 Jul 1.
3
First-dose effect of the SGLT2 inhibitor ipragliflozin on cardiovascular activity in spontaneously diabetic Torii fatty rats.依帕格列净对自发性糖尿病 Torii 肥胖大鼠心血管活性的首剂效应。
Clin Exp Pharmacol Physiol. 2019 Mar;46(3):266-273. doi: 10.1111/1440-1681.13053. Epub 2018 Dec 27.
4
Susceptibility to serious skin and subcutaneous tissue disorders and skin tissue distribution of sodium-dependent glucose co-transporter type 2 (SGLT2) inhibitors.对严重皮肤和皮下组织疾病的易感性和钠依赖性葡萄糖共转运蛋白 2 型（SGLT2）抑制剂的皮肤组织分布。
Int J Med Sci. 2018 Jun 13;15(9):937-943. doi: 10.7150/ijms.22224. eCollection 2018.
5
Combination treatment with ipragliflozin and metformin: a randomized, double-blind, placebo-controlled study in patients with type 2 diabetes mellitus.吡格列酮和二甲双胍联合治疗：2 型糖尿病患者的随机、双盲、安慰剂对照研究。
Clin Ther. 2012 Aug;34(8):1761-71. doi: 10.1016/j.clinthera.2012.06.027. Epub 2012 Jul 15.
6
Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data.依帕列净和其他钠-葡萄糖共转运蛋白 2（SGLT2）抑制剂在 2 型糖尿病治疗中的作用：临床前和临床数据。
Pharmacol Ther. 2013 Jul;139(1):51-9. doi: 10.1016/j.pharmthera.2013.04.003. Epub 2013 Apr 4.
7
Safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): Interim results of a post-marketing surveillance study.依帕列净在老年日本2型糖尿病患者中的安全性（STELLA-ELDER）：一项上市后监测研究的中期结果
Expert Opin Pharmacother. 2016;17(4):463-71. doi: 10.1517/14656566.2016.1145668. Epub 2016 Feb 5.
8
Drug-induced Liver injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report.依帕列净给药所致药物性肝损伤，通过淋巴细胞转化试验（LTT）阳性及罗塞尔·优克福因果关系评估法（RUCAM）确定因果关系：一例报告
Ann Hepatol. 2017 March-April;16(2):308-311. doi: 10.5604/16652681.1231592.
9
Antihyperglycemic effect of ipragliflozin, a sodium-glucose co-transporter 2 inhibitor, in combination with oral antidiabetic drugs in mice.钠-葡萄糖协同转运蛋白2抑制剂依帕列净与口服抗糖尿病药物联合使用对小鼠的降血糖作用
Clin Exp Pharmacol Physiol. 2015 Jan;42(1):87-93. doi: 10.1111/1440-1681.12317.
10
Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats.钠-葡萄糖协同转运蛋白2选择性抑制剂依帕列净对链脲佐菌素诱导的1型糖尿病大鼠高血糖、氧化应激、炎症及肝损伤的影响
J Pharm Pharmacol. 2014 Jul;66(7):975-87. doi: 10.1111/jphp.12223. Epub 2014 Feb 17.

引用本文的文献

1
Cutaneous Adverse Drug Reactions Associated with SGLT2 Inhibitors.与SGLT2抑制剂相关的皮肤药物不良反应
J Clin Med. 2024 Dec 31;14(1):188. doi: 10.3390/jcm14010188.
2
[Not Available].[无可用内容]
CMAJ. 2023 Mar 20;195(11):E430-E431. doi: 10.1503/cmaj.220934-f.
3
Drug eruption associated with empagliflozin.与恩格列净相关的药疹。
CMAJ. 2022 Dec 12;194(48):E1651-E1652. doi: 10.1503/cmaj.220934.
4
Eczematous Drug Eruptions.湿疹样药疹。
Am J Clin Dermatol. 2021 May;22(3):349-366. doi: 10.1007/s40257-021-00586-8. Epub 2021 Feb 15.